Comment on “Belatacept‐based immunosuppression does not confer an increased risk of BK polyomavirus‐DNAemia relative to tacrolimus‐based immunosuppression”

2024-9-14

Disseminated <i>Mycobacterium abscessus</i> secondary to adult onset immunodeficiency syndrome due to anti‐interferon gamma autoantibodies

2024-9-9

Opportunistic viral infections in hepatitis C ‐positive kidney transplant recipients: Cause for concern or reassurance?

2024-9-9

Building a successful transplant research center: Blueprints and barriers

2024-9-9

A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy

2024-9-3

Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival

2024-9-3

Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care

2024-9-3

Donor‐derived infections—Insights from Singapore, Japan, and Thailand

2024-9-3

Benznidazole prophylaxis: A game changer in preventing Chagas disease reactivation in transplant patients

2024-8-27

Postexposure prophylaxis after receipt of MMR vaccine prior to emergent heart transplant

2024-8-26

Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients

2024-8-26

Initial empirical antibiotic therapy in kidney transplant recipients with pyelonephritis: A global survey of current practice and opinions across 19 countries on six continents

2024-8-26

Incidence of opportunistic viral infections in hepatitis C virus nucleic acid test negative recipients of kidneys from hepatitis C virus nucleic acid test positive donors

2024-8-26

Clinical outcomes of lung transplant recipients with pre‐transplant <i>Mycobacterium avium</i> complex infection

2024-8-26

Sulfa allergy labels and risk of opportunistic infections after solid organ transplantation

2024-8-20

Perspectives on donor‐derived infections from the Notify Library

2024-8-19

Donor‐derived dengue infections – A review of screening protocol and outcomes in an endemic country

2024-8-16

Efficacy of dose‐reduced glecaprevir‐pibrentasvir in lung transplant recipients on maintenance cyclosporine from donors with hepatitis C viremia

2024-8-13

Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients

2024-8-13

Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients – A retrospective matched cohort study

2024-8-13

A call to address penicillin allergy labels in patients with hematopoietic stem cell transplants: How to avoid rash decisions

2024-8-5

Issue Information

2024-8-1

Impact of machine perfusion on transplant infectious diseases: New challenges and opportunities

2024-7-30

A rapid point‐of‐care polymerase chain reaction test in suspected viral respiratory tract infection after lung transplantation – A single‐center experience

2024-7-30

Mystery lung mass in a kidney transplant recipient

2024-7-27

Perspectives on biovigilance and transmission of infection of donor origin in deceased organ donation—The evolving scenario in the United Kingdom

2024-7-27

A role for extensive SARS‐CoV‐2 virological assessment of donor and recipient in lung transplantation

2024-7-22

Minimizing risk while maximizing opportunity: The infectious disease organ offer process survey

2024-7-22

Changing the culture of blood cultures: Opportunities for diagnostic stewardship in febrile neutropenia

2024-7-18

Comment on ‘Stopping antibacterial prophylaxis in pediatric allogeneic hematopoietic cell transplantation: An internal audit’

2024-7-18

Stagonospora cutaneous infection in a kidney transplant recipient: First described case in a human

2024-7-18

Outcomes in solid organ transplant recipients receiving organs from a donor with <i>Fusarium solani</i> species complex meningitis

2024-7-16

Clinical approach to donor‐derived infection in solid organ transplant recipients

2024-7-16

Yield of repeat blood cultures in acute myeloid leukemia patients with febrile neutropenia and bacteremia following allogeneic hematopoietic stem cell transplant

2024-7-16

Emerging shadows: HHV‐8‐associated encephalitis unveiled in a solid organ transplant recipient

2024-7-16

Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study

2024-7-15

Malignancy following solid organ transplantation: Current techniques for determination of donor versus recipient origin

2024-7-14

QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation

2024-7-9

Protocol biopsy of kidney allograft enables early detection of BK virus nephropathy to preserve kidney allograft function

2024-7-9

Risk factors for severe outcomes of coronavirus disease 2019 through the waves of the pandemic: Comparing patients with and without solid organ transplantation

2024-7-9

Use of letermovir for cytomegalovirus primary prophylaxis in lung transplant recipients

2024-7-9

Outcomes of kidney transplant recipients exposed to Chagas disease under Benznidazole prophylaxis. A single center 10‐year experience

2024-7-9

Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients

2024-7-9

HHV‐8‐associated diseases in transplantation: A case report and narrative review focused on diagnosis and prevention

2024-7-7

Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient

2024-7-7

The pre‐transplant evaluation: Considerations for trainees and early career transplant infectious diseases clinician

2024-7-5

How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients

2024-7-5

Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?

2024-7-2

Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation

2024-6-30